These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19726087)

  • 21. Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response.
    Westerlind U; Hobel A; Gaidzik N; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2008; 47(39):7551-6. PubMed ID: 18704911
    [No Abstract]   [Full Text] [Related]  

  • 22. Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans.
    Broecker F; Hanske J; Martin CE; Baek JY; Wahlbrink A; Wojcik F; Hartmann L; Rademacher C; Anish C; Seeberger PH
    Nat Commun; 2016 Apr; 7():11224. PubMed ID: 27091615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognition.
    Seppälä U; Selby D; Monsalve R; King TP; Ebner C; Roepstorff P; Bohle B
    Mol Immunol; 2009 Jun; 46(10):2014-21. PubMed ID: 19375166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
    Said Hassane F; Phalipon A; Tanguy M; Guerreiro C; Bélot F; Frisch B; Mulard LA; Schuber F
    Vaccine; 2009 Aug; 27(39):5419-26. PubMed ID: 19559116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
    Radfar S; Wang Y; Khong HT
    J Immunol; 2009 Nov; 183(10):6800-7. PubMed ID: 19846868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
    Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
    FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
    Dippold W; Steinborn A; Meyer zum Büschenfelde KH
    Environ Health Perspect; 1990 Aug; 88():255-7. PubMed ID: 2272320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
    Dziadek S; Kunz H
    Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mutant chaperone converts a wild-type protein into a tumor-specific antigen.
    Schietinger A; Philip M; Yoshida BA; Azadi P; Liu H; Meredith SC; Schreiber H
    Science; 2006 Oct; 314(5797):304-8. PubMed ID: 17038624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth.
    Ruan Z; Yang Z; Wang Y; Wang H; Chen Y; Shang X; Yang C; Guo S; Han J; Liang H; Wu Y
    J Immunother; 2009 Jun; 32(5):486-91. PubMed ID: 19609240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ca antigen is not Thomsen-Friedenreich antigen.
    Harris H; Bramwell ME; McGee JO
    Lancet; 1982 Oct; 2(8304):925-6. PubMed ID: 6126765
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical and chemoenzymatic synthesis of S-linked ganglioside analogues and their protein conjugates for use as immunogens.
    Rich JR; Wakarchuk WW; Bundle DR
    Chemistry; 2006 Jan; 12(3):845-58. PubMed ID: 16196067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis.
    Burden RE; Gormley JA; Jaquin TJ; Small DM; Quinn DJ; Hegarty SM; Ward C; Walker B; Johnston JA; Olwill SA; Scott CJ
    Clin Cancer Res; 2009 Oct; 15(19):6042-51. PubMed ID: 19789302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor IgE adjuvanticity: key role of Fc epsilon RI.
    Nigro EA; Brini AT; Soprana E; Ambrosi A; Dombrowicz D; Siccardi AG; Vangelista L
    J Immunol; 2009 Oct; 183(7):4530-6. PubMed ID: 19748979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thomsen-friedenreich disaccharide immunogenicity.
    Irazoqui FJ; Nores GA
    Curr Cancer Drug Targets; 2003 Dec; 3(6):433-43. PubMed ID: 14683501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis for recognition of breast and colon cancer epitopes Tn antigen and Forssman disaccharide by Helix pomatia lectin.
    Lescar J; Sanchez JF; Audfray A; Coll JL; Breton C; Mitchell EP; Imberty A
    Glycobiology; 2007 Oct; 17(10):1077-83. PubMed ID: 17652409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A molecular approach to immunoscintigraphy: a study of the T-antigen conformation on the surface of tumors.
    Noujaim A; Selvaraj S; Suresh MR; McLean G; Willans D; Turner C; Haines DM; Longenecker BM
    Nuklearmedizin; 1987 Feb; 26(1):1-6. PubMed ID: 2438662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
    Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
    J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.